A MULTICENTER, RANDOMIZED TRIAL OF COMBINATION PEGYLATED INTERFERON-ALPHA 2A PLUS RIBAVIRIN VS. PEGYLATED INTERFERON-ALPHA 2A MONOTHERAPY IN LIVER TRANSPLANT RECIPIENTS WITH RECURRENT HEPATITIS C

被引：0
|
作者：
Gane, Edward J. [1 ]
Strasser, Simone I. [2 ]
Crowford, Darrell H. [3 ]
Ring, John A. [4 ]
Rizkalla, Bishoy [5 ]
Thompson, Sandra J. [5 ]
McCaughan, Geoffrey W. [2 ]
机构：
[1] Auckland City Hosp, New Zealand Liver Transplant Unit, Auckland, New Zealand
[2] Royal Prince Alfred Hosp, AW Morrow GI & Liver Ctr, Sydney, NSW, Australia
[3] Princess Alexandra Hosp, Dept Gastroenterol & Hepatol, Brisbane, Qld 4102, Australia
[4] Flinders Med Ctr, S Australia Liver Transplant Unit, Adelaide, SA, Australia
[5] Roche Prod Pty Ltd, Dee Why, NSW, Australia
来源：
HEPATOLOGY | 2009年 / 50卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
191
引用
收藏
页码：393A / 394A
页数：2
相关论文
共 50 条
  • [21] A randomized controlled trial of pegylated-interferon alpha-2b plus ribavirin vs interferon
    Pol, S
    Perronne, C
    Carrat, F
    Banisadr, F
    Morand, P
    Lunel, F
    Rosenthal, E
    JOURNAL OF HEPATOLOGY, 2003, 38 : 32 - 32
  • [22] Ischemic colitis during pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C
    Leung, Yvette
    Urbanski, Stefan J.
    Schindel, Lynn
    Myers, Robert P.
    CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 20 (10) : 661 - 663
  • [23] Efficacy and Safety of Interferon Alpha 2A and Pegylated Interferon Alpha 2A in Inflammatory Macular Edema
    Couret, Chloe
    Servant, Marion
    Lebranchu, Pierre
    Hamidou, Mohamed
    Weber, Michel
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2020, 28 (02) : 329 - 336
  • [24] Pegylated interferon-alpha 2b monotherapy for haemodialysis patients with chronic hepatitis C - Reply
    Fabrizi, F
    Martin, P
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 20 (01) : 124 - 124
  • [25] Effect of therapy with interferon-alpha and pegylated interferon-alpha on platelet plug formation in patients with chronic hepatitis C
    Homoncik, M
    Jessner, W
    Sieghardt, W
    Gangl, A
    Ferenci, P
    Peck-Radosavljevic, M
    JOURNAL OF HEPATOLOGY, 2003, 38 : 145 - 145
  • [26] A randomized controlled clinical trial on recombinant interferon-alpha 2a in therapy of chronic hepatitis C.
    Xiong, SS
    Mai, K
    Jiang, YS
    Peng, WW
    Qiao, GY
    Chen, YF
    Cui, ZY
    HEPATOLOGY, 1996, 24 (04) : 1891 - 1891
  • [27] Viral kinetics of combination pegylated interferon-α 2A plus ribavirin in patients with hepatitis C cirrhosis
    Gane, EJ
    Holland, J
    Duxfield, J
    Gi, S
    Chapman, B
    Cornelius, D
    Bain, H
    HEPATOLOGY, 2002, 36 (04) : 357A - 357A
  • [28] Pegylated interferon-alpha 2b-ribavirin combination in Egyptian patients with genotype 4 chronic hepatitis
    Derbala, M
    Amer, A
    Bener, A
    Lopez, AC
    Omar, M
    El Ghannam, M
    JOURNAL OF VIRAL HEPATITIS, 2005, 12 (04) : 380 - 385
  • [29] Erythrocyte and plasma ribavirin concentrations in the assessment of early and sustained virological responses to pegylated interferon-alpha 2a and ribavirin in patients coinfected with hepatitis C virus and HIV
    Dominguez, Stephanie
    Ghosn, Jade
    Cassard, Bruno
    Melica, Giovanna
    Poizot-Martin, Isabelle
    Solas, Caroline
    Lascaux, Anne-Sophie
    Bouvier-Alias, Magali
    Katlama, Christine
    Levy, Yves
    Peytavin, Gilles
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2012, 67 (06) : 1449 - 1452
  • [30] Depression during pegylated interferon-alpha plus ribavirin therapy: Prevalence and prediction
    Raison, CL
    Borisov, AS
    Broadwell, SD
    Capuron, L
    Woolwine, BJ
    Jacobson, IM
    Nemeroff, CB
    Miller, AH
    JOURNAL OF CLINICAL PSYCHIATRY, 2005, 66 (01) : 41 - 48
12345